Last reviewed · How we verify

NCT04482452

Percentage Visualized Mucosa as a Marker for the Quality of Colonoscopy

Status unknown Last updated 22 July 2020
What this trial tests

trial testing Colonoscopy in Colonoscopy in 500 participants. Status unknown.

Timeline
8 June 2020
Primary endpoint
19 May 2022
19 May 2022

Quick facts

Lead sponsorInsel Gruppe AG, University Hospital Bern
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment500
Start date8 June 2020
Primary completion19 May 2022
Estimated completion19 May 2022
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

Insel Gruppe AG, University Hospital Bern

Who can join

18 and older, any sex, with Colonoscopy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Primary hypothesis: The percentage of mucosa visualized during the withdrawal of a colonoscopy with reference to the position in the colon by means of the scope-guide is an appropriate parameter for assessment of the quality of colonoscopy and correlates with the probability of the detection of adenomas. Secondary hypothesis: The investigators hypothesize that the percentage of visualized mucosa differs according patient specific parameters (e.g. gender, age, BMI, bowel preparation), procedure specific parameters (e.g. patient position, device, buscopan, fentanyl, withdrawal time) and investigator specific parameters (professional experience as resident and consultant). Study Procedure/Evaluation: The endoscopic images and scope guide from colonoscopy of 500 patients will be filmed. The investigators will correlate the detection of at least one adenoma in the cohort of included patients with the percentage of visualized mucosa during the withdrawal of a colonoscopy. Additional endpoints concerning the quality of the colonoscopy will be assessed as well.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Colonoscopy

Trials testing the same drug.

Other recruiting trials for Colonoscopy

Currently open trials in the same condition.

Other Insel Gruppe AG, University Hospital Bern trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04482452.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing